Data / Form D filings / Quoin Pharmaceuticals, Inc.
Quoin Pharmaceuticals, Inc.: Form D filings
Quoin Pharmaceuticals, Inc., a pharmaceuticals company in Ashburn, VA, filed 2 Form D notices with the SEC between 2020 and 2021. The latest, on April 8, 2021, reports $2 million sold of a $22 million offering to 1 investor.
Find out what Quoin Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 42127 PLEASANT FOREST CT., Ashburn, VA, 20148
- Phone
- (703) 980-4182
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1829165
The full lists. Form D filings in Virginia: 771 rows, $38.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 8, 2021 | New notice | $22,000,000 | $2,000,000 | $20,000,000 | 1 | Mar 25, 2021 | sec.gov |
| Oct 20, 2020 | New notice | $3,000,000 | $710,000 | $2,290,000 | 3 | Oct 5, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| PETER LANKAU | Director | |
| NATALIE LEONG | Director | |
| DENISE CARTER | Executive Officer, Director | |
| MICHAEL MEYERS | Executive Officer, Director | |
| DENNIS LANGER | Director |
Other pharmaceuticals companies in Virginia that filed recently
- Quoin Pharmaceuticals Ltd. $50 million · Sep 10, 2026
Every Form D from the week of Apr 5, 2021 · All recent filings in Virginia · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Quoin Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.